Evidence map›Paper›PMID 41226554›Full record

ArticleInternational journal of molecular sciences2025

Anti-Metastatic Effects of

Supawadee Osotprasit, Saowaros Suwansa-Ard, Scott F Cummins, Tianfang Wang, Tepparit Samrit, Athit Chaiwichien, Stuart J Smith, Narin Changklungmoa, Pornanan Kueakhai

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Molecular Effects ofInternational journal of molecular sciences · 2026
    Article
  2. Suppressive Potential of Ethanolic Extracts ofInternational journal of molecular sciences · 2026
    Article
  3. Anticancer Effects of Sacha Inchi (International journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Supawadee OsotprasitFaculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.
Saowaros Suwansa-ArdCentre for Bioinnovation, University of the Sunshine Coast, Maroochydore, QLD 4558, Australia.ORCID 0000-0002-9129-2082
Scott F CumminsCentre for Bioinnovation, University of the Sunshine Coast, Maroochydore, QLD 4558, Australia.ORCID 0000-0002-1454-2076
Tianfang WangCentre for Bioinnovation, University of the Sunshine Coast, Maroochydore, QLD 4558, Australia.ORCID 0000-0002-4876-7767
Tepparit SamritFaculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.
Athit ChaiwichienFaculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.
Stuart J SmithCentre for Bioinnovation, University of the Sunshine Coast, Maroochydore, QLD 4558, Australia.ORCID 0009-0002-3656-2673
Narin ChangklungmoaFaculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.
Pornanan KueakhaiFaculty of Allied Health Sciences, Burapha University, Chonburi 20131, Thailand.

Funding

National Research Council of Thailand N41A650402
6 · The paper itself

Abstract

Colorectal cancer treatment primarily relies on chemotherapy, which often causes significant side effects. Sacha inchi, a plant known in traditional medicine, has shown promise in various therapeutic applications. However, despite its potential, the specific mechanisms remain poorly understood, particularly regarding its husk components. This study investigates sacha inchi husk extract's chemical properties and its effects on human colorectal cancer cells. GC/MS and LC/MS analyses revealed a rich profile of phenolic and flavonoid compounds, with naringenin and lidocaine as predominant components. The extract demonstrated significant dose-dependent inhibition of colorectal cell migration, invasion, and colony formation while exhibiting no cytotoxicity toward normal colon epithelial cells. Transcriptomic and proteomic analyses showed downregulation of migration- and invasion-related genes in cancer cells, and Western blot analysis confirmed reduced expression of MMP2, MMP9, and N-cadherin. EGFR pathway analysis showed decreased expression of RAS (-0.2-fold), MAK (-0.26-fold), and ERK (-0.54-fold) genes, indicating suppression of epithelial-mesenchymal transition (EMT). These findings demonstrate that sacha inchi husk extract effectively inhibits metastasis in colorectal cancer cells through the upstream (EGFR) and downstream (EMT) pathways, suggesting its potential as a dietary supplement or therapeutic agent for colorectal cancer treatment. Our research provides evidence for the development of natural, less toxic alternatives.

Indexed as

Antineoplastic Agents, PhytogenicColonic NeoplasmsEpithelial-Mesenchymal TransitionPlant ExtractsCell Line, TumorCell MovementCell ProliferationErbB ReceptorsGene Expression Regulation, NeoplasticHumansSignal TransductionAntineoplastic Agents, PhytogenicEGFR protein, humanErbB ReceptorsPlant Extractsanticancer activitychemical propertiescolorectal canceromicssacha inchi

Identifiers

PMID41226554
PMCPMC12607394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.